Curbline Properties Corp. CURB 深 滬
等待開盤 01-29 09:30:00 美东时间
23.56
-0.240
-1.01%
華盛通- 最 高24.028
- 今 開23.81
- 成交量 40.04万股
- 最 低 23.45
- 昨 收 23.80
- 總市值 24.74亿
- 52周最高 25.02
- 市盈率 靜 248.00
- 換手率 0.38%
- 52周最低 20.40
- 委 比 68.50%
- 總股本 1.05亿
- 歷史最高 25.02
- 量 比 0.54
- 振 幅 2.43%
- 歷史最低 19.24
- 每 手 1
- 風險率 0.74%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Curbline Properties Corp. to Release Earnings and Host Conference Call
Curbline Properties Corp. to Release Earnings and Host Conference Call Curbline Properties Corp. will release its fourth quarter financial and operational results before the market opens on February 9, 2026. The company will host its Fourth Quarter Earnings Conference Call and audio webcast on Febru
01-27 05:05
The best small and mid-cap real estate companies by earnings momentum
With the arrival of earnings season, investors may want to identify real estate companies that have seen the most favorable analyst revisions to their earnings estimates. Positive EPS revisions can si...
01-17 02:53
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
美股大行评级 | 拼多多、小鹏获Freedom上调目标价；多家大行首予Wealthfront"超配"评级，目标价最高23美元
今日重点评级关注：HC Wainwright & Co.：维持MetaVia Inc."买入"评级，目标价从12美元升至40美元；Canaccord Genuity：维持GH Research"买入"评级，目标价从35美元升至39美元
01-07 17:25
Morgan Stanley Maintains Overweight on Curbline Properties, Raises Price Target to $29
Morgan Stanley analyst Ronald Kamdem maintains Curbline Properties (NYSE:CURB) with a Overweight and raises the price target from $27 to $29.
01-06 23:28
美股大行评级 | 潜在涨幅218.88%！Kyverna Therapeutics获摩根士丹利升目标价至25美元，维持"超配"评级
今日重点评级关注：摩根士丹利：维持Kyverna Therapeutics"超配"评级，目标价从20美元升至25美元；Maxim Group：维持Capricor Therapeutics"买入"评级，目标价从25美元升至50美元
2025-12-05 08:35
Keybanc Upgrades Curbline Properties to Overweight, Announces $27 Price Target
Keybanc analyst Todd Thomas upgrades Curbline Properties (NYSE:CURB) from Sector Weight to Overweight and announces $27 price target.
2025-12-04 21:04
美股大行评级 | 摩根大通上调百度至"超配"，目标价升至188美元！Navan获多家机构首予"买入"评级，目标价最高30美元
今日重点评级关注：巴克莱：维持Iovance Biotherapeutics"超配"评级，目标价从4美元升至9美元；BTIG：维持Cullinan Therapeutics"买入"评级，目标价从32美元升至38美元
2025-11-25 10:27
美股大行评级 | 高盛上调百度、美敦力、晶科能源等多只个股目标价；家得宝遭9家机构下调目标价；
今日重点评级关注：富国银行：维持Annexon"超配"评级，目标价从14美元升至27美元；瑞穗：上调Relmada Therapeutics评级至"跑赢大市"，目标价从1美元升至10美元
2025-11-20 10:28
Citigroup Upgrades Curbline Properties to Buy, Raises Price Target to $27
Citigroup analyst Craig Mailman upgrades Curbline Properties (NYSE:CURB) from Neutral to Buy and raises the price target from $25 to $27.
2025-11-19 20:11
